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 Osteoarthritis is a leading cause of disability in the United States. Current methods of 
treatment aim to replace cartilage as opposed to regenerating tissue. There is interest in using 
stem cells as a source of growth factors to stimulate cartilage cells to produce extracellular 
matrix and an environment conducive to cartilage regeneration. The purpose of this study is to 
assess the effect of chemical and biological stimulation and a 3 dimensional structural 
environment on mRNA levels of adipose-derived stem cells in vitro and on cartilage 
regeneration in vivo. Adispose-derived stem cells (ASCs) were isolated from rats, 
microencapsulated, and treated with chondrogenic media. Chondrogenic media (CM) increased 
mRNA levels of many genes involved in chondrogenesis, including comp, acan, colX, and tgfb3, 
and decreased levels of the angiogenic factors fgf2 and vegfa. Microencapsulation increased 
mRNA levels of pthlh and tgfb3, and there was little difference on mRNA levels between 
calcium and barium crosslinks. The chemical components, ascorbic acid 2-phosphate (AA2P) 
and dexamethasone (Dex), and biological components, growth factors TGF-B1 and BMP-6, or 
chondrogenic media were assessed for their effect on ASC gene profile. Removing growth 
factors reduced mRNA levels of all genes assessed, whereas removing Dex and AA2P had 
variable effects on mRNA levels. ASCs were microencapsulated and preconditioned with CM 
prior to transplantation in a 2 mm cartilage defect in rats. The in vivo results displayed moderate 
cartilage infiltration into the defect. These data suggest that microencapsulation and treatment 
with CM can alter the gene profile to be conducive to cartilage regeneration and may regenerate 





 Osteoarthritis, a joint disorder characterized by the wearing down of cartilage and 
underlying bone, is the leading cause of chronic disability in the United States [1]. There is no 
cure for osteoarthritis, and current treatments aim solely to alleviate pain or surgically replace the 
cartilage [2]. However, treatments using direct implantation of cartilage cells have shown 
minimal success. Over time cartilage loses the ability to regenerate itself. Therefore, there is 
interest in stimulating the existing chondrocytes to secrete growth factors and produce 
extracellular matrix proteins that could assist in regeneration. 
 Stem cells have shown to be a promising source of cartilage regeneration. Adipose-
derived stem cells (ASCs) are useful for cartilage regeneration due to their chondrogenic 
potential, production of chondrogenic trophic factors, and abundance in the body [3]. ASCs, 
however, have the potential to produce factors involved in angiogenesis, which is detrimental to 
cartilage growth [4]. Current studies in gene therapy have been able to increase production of 
certain growth factors that stimulate chondrogenesis one at a time [5]. Cartilage regeneration, 
however, is a multifactorial process in which many growth factors contribute to condrogenesis, 
and gene therapy does not alter the entire secretory profile [6]. Thus, chondrogenic media, 
including ascorbic acid-2-phosphate, dexamethasone, and the growth factors BMP-6, and Tgfb-
1, may be used to differentiate ASCs towards a chondrogenic phenotype and stimulate 
production of many chondrogenic growth factors, while inhibiting production of angiogenic 
factors [7]. 
 It is known that chemical and biological factors, such as chondrogenic media, and the 
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cell’s environment, such as a 3D scaffold, may promote chondrogenesis. It is unknown, however, 
what the effect of different components of chondrogenic media and differing structural 
environments are on the secretory profile of ASCs. Therefore, the purpose of this study was to 
determine the effect that chondrogenic media has on ASC growth factor production in a 3D 
environment, the effect of the different components of chondrogenic media on growth factor 
production, and if ASCs preconditioned in chondrogenic media can regenerate cartilage in vivo. 
It was hypothesized that treatment of ASCs with chondrogenic media in a 3D structural 
environment would promote expression and secretion of chondrogenic growth factors in vitro, 
and cartilage regeneration in vivo. 
3 
CHAPTER 2 
METHODS AND MATERIALS 
 
Cell Isolation 
ASCs were isolated from male Sprague-Dawley rats and cultured in Lonza Mesenchymal 
Stem Cell Growth Medium (MSCGM).  ASCs were isolated using fluorescence activated cell 
sorting to be negative for CD45 and positive for CD73 and CD271.  Resting chondrocytes were 
isolated from the ribs of male Sprague Dawley rats and cultured in Dulbecco’s modified Eagle 
medium (DMEM) containing 10% fetal bovine serum (FBS) and 50 µg/ml ascorbic acid until 
fourth passage prior to experimental analysis.  
Microencapsulation 
When primary ASCs reached 90% confluence, cells were trypsinized and 
microencapsulated in low molecular weight (~150 kDa) alginate with a high mannuronate to 
guluronate ratio. The alginate (20 mg/mL) was dissolved in sterile-filtered saline.  Cells were 
suspended in the alginate solution at a concentration of 25×106 cells/mL.  Microbeads were 
formed using a Nisco Encapsulator VAR V1 LIN-0043 and a cross-linking solution of 50 mM 
CaCl2, 150 mM glucose, and 15 mM HEPES buffer. The microbeads were washed three times in 
MSCGM prior to cell culture studies.   
Cell Culture  
Once first passage ASCs reached 90% confluence, ASC monolayers and microbeads 
were then treated for 5 days with either MSCGM or chondrogenic medium (CM) consisting of 
DMEM containing 4.5g/L glucose with 1 mM sodium pyruvate, 40 µg/ml proline, 50 µg/ml 
ascorbic acid 2-phosphate (AA2P), 1% ITS+, 100 nM dexamethasone (Dex), 10 ng/ml 
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recombinant human transforming growth factor beta-1 (TGF-β1) and 100 ng/ml recombinant 
human bone morphogenic protein 6 (BMP-6).  In subsequent studies, ASC monolayers were 
treated for five days with either MSCGM supplemented with different combinations of 50µg/mL 
AA2P, 100nM Dex, 10ng/mL TGF-β1, and 100ng/mL BMP-6 or with CM that lacked different 
combinations of 50µg/mL AA2P, 100nM Dex, 10ng/mL TGF- β1, and 100ng/mL BMP-6.  Once 
media were changed on the fifth day, RNA was collected after 8 hours as described below.  
Conditioned media and ASCs were collected after 24 hours, and ASCs were lysed in 0.05% 
Triton X-100.   
RNA Isolation and Reverse Transcription 
Alginate microbeads were uncross-linked in 82.5 mM sodium citrate (Sigma), pelleted at 
500×g for 10 minutes and washed two more times in sodium citrate to remove any residual 
alginate.  TRIzol reagent (Invitrogen) was added to the resulting cell pellet, homogenized using a 
QIAshredder (QIAGEN, Valencia, CA, USA), and RNA was isolated using chloroform and an 
RNeasy Kit (QIAGEN) as previously described [28].  1 µg RNA was then reverse transcribed to 
cDNA using a High Capacity Reverse Transcription cDNA kit (Applied Biosystems, Carlsbad, 
CA, USA).   
Microarray Analysis 
 cDNA was converted into cRNA using a RNA transcript labeling kit (Enzo Diagnostics, 
Farmingdale, NY, USA).  Biotin labeled cRNA was cleaned up using a GeneChip Sample 
Cleanup Module (Affymetrix Inc., Santa Clara, CA, USA) and fragmented at 94°C in 
Fragmentation Buffer for 35 minutes.  Following fragmentation, 15 µg biotinylated cRNA was 
hybridized to an Affymetrix Rat  Genome GeneChip (Rat 230_2.0) at 45°C for 16 hours, 
washed, stained with streptavidin phycoerythrin (Fluidics Station 400, Affymetrix), and scanned 
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according to manufacturer’s guidelines.   The GeneChips were then assessed for data quality 
using Affymetrix-developed quality controls.  Data analysis was performed using GeneSifter 
(Geospiza, Seattle, WA) with significant differences in expression of a single gene being defined 
as a 3-fold change in mRNA levels.  Significant differences in mRNAs of Kyoto Encyclopedia 
of Genes and Genomes (KEGG) pathways were defined as z-scores greater than 2.0.   RNA 
isolated from rat liver tissue served as a reference control. 
Growth Factor mRNA Levels and Production 
Chondrogenesis is a complex process orchestrated by a wide array of growth factors.  
Therefore, mRNA levels and production of paracrine factors involved chondrocyte proliferation, 
proteoglycan synthesis, hypertrophic differentiation, and vascular invasion were quantified.  
Along with these paracrine factors, mRNAs for chondrocytic markers were also quantified as 
previously described using real-time PCR with gene-specific primers using the Step One Plus 
Real-time PCR System and Power Sybr® Green Master Mix (Applied Biosystems) [29].  All 
primers were designed using Beacon Designer software (Premier Biosoft, Palo Alto, CA, USA) 
and synthesized by Eurofins MWG Operon (Huntsville, AL, USA), unless otherwise noted 
(Table 1).  Growth factor production over the last 24 hours of culture was quantified using 
ELISA (R&D Systems) and normalized to DNA content measured with a Quant-iT PicoGreen 
kit (Invitrogen).  To measure growth factor retention within the microbead, cultures were 
uncrosslinked in 82.5mM sodium citrate and the supernatants and cells were frozen at -80oC.  
Samples were then lyophilized for 24 hours and the resulting dried constructs were digested in 1 
unit/mL alginate lyase (Sigma) for 1 hour and measured with ELISA. 
Xiphoid Defect 
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 To assess the effects of ASCs on cartilage regeneration, 2 mm cylindrical defects were 
made in the xiphoids of 125g male Sprague-Dawley rats as previously described [30] under a 
protocol approved by the Institutional Animal Care and Use Committee of the Georgia Institute 
of Technology.  ASC microbeads preconditioned with MSCGM or CM were implanted into the 
defect and immobilized with a hydrogel mixture consisting of 25 mg/mL RGD-conjugated 
alginate (NOVATACH M RGD, FMC BioPolymer) in DMEM to promote cell infiltration and 
20 mg/mL CaSO4 (Sigma) mixed at a 4:1 volume ratio.  Empty defects with the hydrogel mixture 
and re-implanted excised cartilage (autografts) served as controls.  All groups were tested in 7 
rats.  35 days post operation, the xiphoids were excised and fixed in 10% phosphate-buffered 
formalin (Sigma) for 48 hours and embedded in paraffin.  Sagittal sections of the defect were 
stained with safranin-O using a fast green counter stain to evaluate proteoglycan present.   
Statistical Analysis 
Statistical differences among all experimental groups were determined via ANOVA with 
a post hoc Tukey test (GraphPad Prism, La Jolla, CA, USA).  Statistical differences between 
control and experimental groups were determined via Student’s t-test.  Differences in means 
were considered to be statistically significant if the p-value was less than 0.05.  All in vitro 
experiments had six independent cultures per treatment group to ensure sufficient power to 
detect statistically significant differences and were conducted multiple times to validate the 
observations.  However, only data from a single representative experiment are shown and are 





Effect of chondrogenic media and structural environment on chondrogenic phenotype  
 To assess effects of chondrogenic media and different structural environments on mRNA 
levels of genes involved in chondrogenesis, ASCs were microencapsulated in alginate and 
treated with chondrogenic media (CM). CM increased mRNA levels of various genes involved in 
chondrogenesis, including comp, acan, colX, and tgfb3, compared to monolayer cells treated 
with MSCGM alone (Figure 1). Nog, a bone morphogenic protein (BMP) inhibitor, showed 
highly increased expression in the monolayer ASCs treated with CM, but this effect was 
diminished when the cells were microencapsulated. CM also decreased mRNA levels of the 
angiogenic factors fgf2 and vegfa. Microencapsulation alone increased mRNA levels of tgfb3. 
Col2, an important component of the extracellular matrix of chondrocytes, showed highest 
expression when ASCs in microencapsulated cells were treated with CM.  
  To determine if the interaction between CM and microencapsulation was significant, a 3-
Way ANOVA was conducted on data of mRNA levels of 13 genes quantified for CM, 
microencapsulation, and time. The interaction between chondrogenic media (CM) and 
microencapsulation (uE) was for mRNA levels of nog, pthlh, and tgfb3 (Figure 2). Over a two 
week span, time had no significant effect on any mRNA levels assessed.  
 Different crosslinkers, calcium and barium, were used to determine if altered chemical 
composition of the microbeads would have an effect on mRNA levels of ASCs. 
Microencapsulation in both barium and calcium crosslinks increased mRNA levels of tgfb3 and 
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pthlh, and decreased levels of fgf2, compared to monolayer ASCs (Figure 3). Barium crosslinks 








Figure 1. Heat map displaying relative quantities of each of the 13 genes 
quantified for treatment over control (monolayer cells with MSCGM). 
 
Figure 2. 3-Way ANOVA of 
to assess effect of 
chondrogenic media, 
microencapsulation (uE), time 
and interactions on mRNA 







Effect of chondrogenic media components on chondrogenic phenotype 
 To determine the effect of individual components of chondrogenic media, monolayer 
ASCs were treated with all combinations of the components of chondrogenic media: 50µg/mL 
ascorbic acid 2-phosphate (AA2P), 100nM dexamethasone (Dex), 10ng/mL TGF-β1, and 
100ng/mL BMP-6. Removing Dex from CM significantly increased mRNA for comp and 
decreased mRNA levels for bmp2 and nog (Figure 4). Eliminating both Dex and AA2P increased 
mRNA levels of pthlh, tgfb3, and vegfa. Removing ascorbic acid 2-phosphate decreased mRNA 





Figure 3. Gene expression of 
hASCs microencapsulated 
(uB) using a barium (Ba) or 
calcium (Ca) crosslinker 










Figure 4. mRNA levels of monolayer ASCs treated with combination of TGF-
B1, BMP-6, dexamethasone (Dex), and ascorbic acis 2-phosphate (AA2P). 
*p<0.05 vs. complete chondrogenic media (CCM), ^p<0.05 vs. -TGF-B1, 
#p<0.05 vs. -BMP-6, $p<0.05 vs. –AA2P, &p<0.05 vs. -Dex. 
11 
Effect of microencapsulation and CM on cartilage regeneration in vivo 
 
 To confirm the results shown in vitro, that microencapsulated ASCs treated with 
chondrogenic media demonstrate a chondrogenic phenotype, a 2 mm cartilage defect was created 
in rats. Microencapsulated ASCs preconditioned with chondrogenic media were injected into the 
defect, with a cartilage autograft, microencapsulated ASCs treated with standard growth media, 
and an empty defect serving as controls. Histological samples of the defects were prepared and 
stained for chondrocytes. Defects treated with hydrogel alone showed no cell infiltration into the 
defect and a lack of fast green staining (Figure 5A). Microencapsulated ASCs preconditioned in 
MSCGM (Figure 5B) and CM (Figure 5C) showed little cell infiltration into the defect. 




Figure 5. (A) RGD-conjugated hydrogel, (B) ASC microbeads preconditioned with the 
GM and RGD-conjugated hydrogel, (C) ASC microbeads preconditioned with the CM 
and RGD-conjugated hydrogel, and (D) autograft. Sections were stained with safranin-O 





 Stem cell therapies have been investigated as a method of tissue regeneration. Current 
therapies to differentiate stem cells into the desired tissue have shown promising results, but 
have been yet to approved by the FDA. A potential method of regeneration is stimulating stem 
cells to release trophic factors to promote an environment of tissue regeneration. This is the first 
extensive study to demonstrate that microencapsulation and chondrogenic media components 
have different effects on the gene profile of ASCs and that microencapsulated ASCs 
preconditioned in CM can promote cartilage regeneration in vivo.  
 Chondrogenic media was shown to increase mRNA levels of a variety of genes involved 
in chondrogenesis and maintaining the cartilage phenotype. Acan, which is responsible for giving 
cartilage its compressive properties, and comp, which is a significant component in the 
extracellular matrix of cartilage, were both upregulated when treated with CM. Nog, a BMP 
inhibitor, was shown to be upregulated with CM treatment, which may assist in chondrogenesis 
by inhibiting cells from undergoing osteogenesis after chondrogenesis. The growth factor tgfb3, 
which stimulates cartilage proliferation and differentiation, was upregulated after CM treatment. 
CM treatment and microencapsulation decreased angiogenic factors, which is also important in 
stimulating ASCs to differentiate into avascular chondrocytes instead of vascular osteoblasts. 
The interaction between microencapsulation and CM was significant in three of thirteen genes 
quantified, suggesting that there could be an additional benefit in using both treatments as 
opposed to microencapsulation or CM alone. It should be noted, however, that 
microencapsulation alone increased expression of some angiogenic factors, suggesting that the 
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structural environment alone may promote ASCs to secrete angiogenic factors and deter the 
process of chondrogenesis. 
 Different microbead crosslinks did not have an effect on mRNA levels, suggesting that it 
is the 3D environment alone, as opposed to the barium or calcium, responsible for altering gene 
expression. The time points investigated did not have an effect on mRNA levels. Thus, there 
could be sustained expression of these growth factors over a two-week period, which would be 
translatable to therapeutic treatment. 
 In regards to individual components of CM, growth factors were shown to have a large 
impact on mRNA levels of chondrogenic genes. Dexamethasone, a potent steroid, was important 
in reducing levels of vegfa, a growth factor involved in angiogenesis. Inhibition of this gene 
would promote chondrogenesis by reducing the likelihood of osteogenesis occurring. The effect 
of AA2P was variable amongst different genes. This could be explained by the fact that AA2P, a 
derivative of Vitamin C, is involved in a variety of pathways, which could have variable 
downstream signaling effects on mRNA levels of different genes. 
 Microencapsulation alone of cells treated with MSCGM showed some extracellular 
matrix deposition throughout the defect, evidenced by fast green staining. This could be 
explained by the fact that the 3D structural environment alone may induce growth factor 
production. Preconditioning with CM appears to have a similar effect, increasing protein 
deposition throughout the defect. Complete cartilage infiltration and regeneration, however, was 
not seen in the defect at 35 days. This suggests that it may have been necessary to leave the 
microbeads for longer time points to assess the extent of regeneration. Furthermore, growth 
factors may have been secreted early in the regeneration process, and therefore cease to have an 
effect over the extent of the 35 day period. A method of controlled release of the factors from the 
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microbeads may better promote chondrogenesis by providing a constant stream of growth 
factors. 
 Adipose derived stem cells have shown their capability to produce a variety of 
chondrogenic factors, particularly when preconditioned with chondrogenic medium. Alginate 
microbeads, which are non-immunogenic, enable localized transport of these ASCs to the site of 
regeneration. These ASCs may not only differentiate into chondrocytes, but also secrete 
therapeutic factors that promote extracellular matrix growth. Together these results suggest a 
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